• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用于治疗失眠的医用大麻。

Medical cannabis for the treatment of insomnia.

作者信息

Varela Lucia B, Escobar Liquitay Camila Micaela, Díaz Menai Samanta, Garegnani Luis

机构信息

Universidad Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Department of Neurology, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.

出版信息

Cochrane Database Syst Rev. 2025 Apr 3;4(4):CD016216. doi: 10.1002/14651858.CD016216.

DOI:10.1002/14651858.CD016216
PMID:40178061
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11967163/
Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of medical cannabis on adults with insomnia.

摘要

这是一项Cochrane系统评价（干预措施）的方案。目标如下：评估医用大麻对成年失眠患者的影响。

相似文献

1
Medical cannabis for the treatment of insomnia.用于治疗失眠的医用大麻。
Cochrane Database Syst Rev. 2025 Apr 3;4(4):CD016216. doi: 10.1002/14651858.CD016216.
2
Medical Cannabis for Insomnia in a Patient With Advanced Breast Cancer.医用大麻用于一名晚期乳腺癌患者的失眠治疗。
J Pain Symptom Manage. 2023 May;65(5):e497-e502. doi: 10.1016/j.jpainsymman.2023.01.002. Epub 2023 Jan 11.
3
Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial.医用大麻持有对成人疼痛、失眠和情绪障碍症状的影响：一项随机临床试验。
JAMA Netw Open. 2022 Mar 1;5(3):e222106. doi: 10.1001/jamanetworkopen.2022.2106.
4
[Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].[大麻对多发性硬化症、神经性疼痛患者以及接受化疗的肿瘤患者安全性和治疗效果的系统评价]
Epidemiol Prev. 2017 Sep-Dec;41(5-6):279-293. doi: 10.19191/EP17.5-6.AD01.069.
5
Suan-Zao-Ren decoction for insomnia: A protocol for a systematic review and meta-analysis.酸枣仁汤治疗失眠：一项系统评价与荟萃分析方案
Medicine (Baltimore). 2020 Aug 21;99(34):e21658. doi: 10.1097/MD.0000000000021658.
6
Cannabinoids, Insomnia, and Other Sleep Disorders.大麻素、失眠和其他睡眠障碍。
Chest. 2022 Aug;162(2):452-465. doi: 10.1016/j.chest.2022.04.151. Epub 2022 May 7.
7
Wendan decoction for primary insomnia: Protocol for a systematic review and meta-analysis.温胆汤治疗原发性失眠：系统评价与Meta分析方案
Medicine (Baltimore). 2017 Nov;96(47):e8906. doi: 10.1097/MD.0000000000008906.
8
Medicinal cannabis improves sleep in adults with insomnia: a randomised double-blind placebo-controlled crossover study.药用大麻可改善成人失眠患者的睡眠：一项随机双盲安慰剂对照交叉研究。
J Sleep Res. 2023 Jun;32(3):e13793. doi: 10.1111/jsr.13793. Epub 2022 Dec 20.
9
Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial.评估夜间给予口服大麻药物的失眠患者次日可能出现的损害：一项先导随机对照试验。
Psychopharmacology (Berl). 2024 Sep;241(9):1815-1825. doi: 10.1007/s00213-024-06595-9. Epub 2024 May 17.
10
Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis.大麻素治疗失眠症：系统评价和荟萃分析。
CNS Drugs. 2020 Dec;34(12):1217-1228. doi: 10.1007/s40263-020-00773-x. Epub 2020 Nov 26.

本文引用的文献

1
Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial.评估夜间给予口服大麻药物的失眠患者次日可能出现的损害：一项先导随机对照试验。
Psychopharmacology (Berl). 2024 Sep;241(9):1815-1825. doi: 10.1007/s00213-024-06595-9. Epub 2024 May 17.
2
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023.《欧洲失眠症指南：2023 年失眠症的诊断和治疗更新》。
J Sleep Res. 2023 Dec;32(6):e14035. doi: 10.1111/jsr.14035.
3
Cannabis-based medicines and medical cannabis for adults with cancer pain.癌症疼痛成人患者使用大麻类药物和医用大麻。
Cochrane Database Syst Rev. 2023 Jun 5;6(6):CD014915. doi: 10.1002/14651858.CD014915.pub2.
4
Differentiating Cannabis Products: Drugs, Food, and Supplements.区分大麻产品：药品、食品和补充剂。
Front Pharmacol. 2022 Jun 27;13:906038. doi: 10.3389/fphar.2022.906038. eCollection 2022.
5
Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline.医用大麻或大麻素治疗慢性疼痛：临床实践指南。
BMJ. 2021 Sep 8;374:n2040. doi: 10.1136/bmj.n2040.
6
Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo.用医用大麻治疗失眠症状：一种比较大麻素药物与安慰剂疗效的随机、交叉试验。
Sleep. 2021 Nov 12;44(11). doi: 10.1093/sleep/zsab149.
7
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明：系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
8
Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders.大麻素对睡眠的影响及其在睡眠障碍治疗中的潜力。
Neurotherapeutics. 2021 Jan;18(1):217-227. doi: 10.1007/s13311-021-01013-w. Epub 2021 Feb 12.
9
Incidence, Persistence, and Remission Rates of Insomnia Over 5 Years.5年间失眠症的发病率、持续率和缓解率
JAMA Netw Open. 2020 Nov 2;3(11):e2018782. doi: 10.1001/jamanetworkopen.2020.18782.
10
How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods.健康相关生活质量量表中的最小临床重要差异是如何确定的？对锚定物和方法的综述。
Health Qual Life Outcomes. 2020 May 12;18(1):136. doi: 10.1186/s12955-020-01344-w.